Dr. Rapoport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-1230Fax+1 410-328-1975- Is this information wrong?
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 1989 - 1993
- University of RochesterResidency, Internal Medicine, 1986 - 1989
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- PA State Medical License 1993 - Present
- MD State Medical License 1997 - 2025
- NY State Medical License 1987 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1998 Sep 01
- Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 1999 Mar 01
- Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma Start of enrollment: 2001 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia.Aaron P Rapoport> ;Haematologica. 2024 Apr 1
- 3 citationsBridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.Michael D Jain, Miriam T Jacobs, Feng Gao, Loretta J Nastoupil, Jay Y Spiegel, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwo...> ;Blood Advances. 2024 Feb 27
- Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising vir...Kocoglu, M., Richardson, P., Mo, C., Rapoport, A., Atanackovic, D.> ;Haematologica. 2024 Feb 22
- Join now to see all
Journal Articles
- Final Outcomes of Escalated Melphalan 280 mg/m2 with Amifostine Cytoprotection Followed Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: High C...Neal Flomenberg, Dianna S Howard, Barry R Meisenberg, Parameswaran Hari, Gordon L Phillips, David H Vesole, Jasleen Randhawa, Aaron P Rapoport, Nature
Lectures
- Clinical Predictors of T Cell Fitness for CAR T Cell Manufacturing and Efficacy in Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Maryland Governor's Cancer in Remission; Treatment ContinuesNovember 17th, 2015
- Immunotherapy Is the Future of Cancer Research: 70% of Multiple Myeloma Patients Find Recovery with New TreatmentJuly 20th, 2015
- Gene Therapy Could Treat Cancer, Study FindsMarch 22nd, 2013
Grant Support
- Immunotherapy After ASCT For MM Using Htert Vaccination + Vaccine-Primed T CellsNational Cancer Institute2007–2009
- Immune Responses To T-Cell Expansion + PCV ImmunizationNational Cancer Institute2004–2005
Professional Memberships
- Member
Hospital Affiliations
- University of Maryland Baltimore Washington Medical CenterGlen Burnie, Maryland
- University of Maryland Medical CenterBaltimore, Maryland
- Veterans Affairs Maryland Health Care System-Baltimore DivisionBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: